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INVESTIGATION OF THE PATHOLOGICAL FUNCTION OF PGC1B IN THE 
RETINAL PIGMENT EPITHELIUM AND ITS IMPLICATIONS FOR AGE-
RELATED MACULAR DEGENERATION 
QUINCY CHARLES 
ABSTRACT 
 Age-Related Macular Degeneration (AMD) is a retinal eye disease that is the 
leading cause of blindness in those over 50 years of age throughout the developed world. 
Oxidative and metabolic dysfunction of the retinal pigment epithelium (RPE) has been 
shown to play an important role in AMD. However, the mechanism of dysfunction in the 
RPE is poorly understood. The peroxisome proliferator-activated receptor-gamma 
coactivator 1α and β (PGC1A and PGC1B) are coactivators that interact with 
transcription factors to regulate mitochondria metabolism. In a previous study, it was 
demonstrated that one of the isoforms, PGC1A, protects RPE cells from oxidative stress 
through the upregulation of transcription factors that regulate important antioxidant 
enzymes. There is experimental and clinical evidence that demonstrates that PGC1B may 
play a deleterious role in the RPE cell. The objective of this study is to characterize the 
pathological effect of PGC1B on the RPE cell.    
 PGC1B was overexpressed in the human retinal pigment epithelium cell line 
(ARPE-19) and expression of the PGC1 isoforms and their main gene targets was 
evaluated using quantitative polymerase chain reaction (qPCR). Cell death was evaluated 
under basal and pro-oxidant conditions by quantification of lactate dehydrogenase (LDH) 
release from the RPE cell. The effect of PGC1B gain of function on the RPE pro-
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angiogenic function was evaluated using the choroid explant sprouting assay and by 
testing the proliferative, migratory, and tube formation potential of RPE-derived 
conditioned media on the rhesus monkey chorioretinal cell line (RF/6A).   
 Quantitative PCR analysis showed that overexpression of PGC1B in ARPE-19 
cells leads to increased mitochondrial metabolism and decreased antioxidant enzyme 
expression, causing oxidative stress. After treatment with H2O2, PGC1B overexpression 
caused ARPE-19 cells to become more susceptible to cytotoxicity. The ex vivo choroid 
sprouting assay demonstrated that PGC1B overexpression in RPE is pro-angiogenic. 
However, cell proliferation as measured by MTT and the cell migration assay provided 
conflicting results on the pro-angiogenic effect of PGC1B. 
 Previous research has demonstrated that oxidative stress in the RPE cell plays a 
role in AMD progression. It has been demonstrated in this study that PGC1B expression 
leads to increased mitochondrial metabolism and repression of antioxidant enzymes 
needed to prevent oxidative stress and dysfunction in the RPE cell. While experiments to 
test the effect of PGC1B on angiogenesis provided conflicting results, a different 
endothelial cell model may be better suited in demonstrating the pro-angiogenic effect of 
PGC1B. The hope is that the information provided from this study may be used to further 
our understanding of AMD and lead to the development of therapeutic targets to combat 
the effects of AMD. 
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INTRODUCTION 
 
Age-Related Macular Degeneration 
Age-Related Macular Degeneration (AMD) is a retinal eye disease that affects the 
macula which is located in the center of the retina and is essential for high resolution 
color vision and visual acuity. AMD is the major cause of blindness in individuals over 
the age of 50 across the developed world.1 In 2010, it was estimated that 9.1 million 
people in the United States had early AMD and this number is forecasted to significantly 
increase to 17.8 million by 2050.2 Some of the factors that increase the risk of AMD 
include advanced age,3 smoking,4,5 family history,6 European origin,7 and genetic 
mutations.8-12  
As a person ages, there is an increased deposition of debris, called drusen, 
between the retinal pigment epithelium (RPE) and the Bruch’s membrane of the choroid 
in the posterior eye. Drusen can be visualized during ophthalmic observation of the 
fundus of the eye and appears as yellow lesions. The mere presence of small drusen 
particles (less than 63µm in size) during a funduscopic examination of the eye does not 
automatically indicate that one has AMD but the presence of larger sized drusen (greater 
than 63µm) can lead to development of the disease.13,14 
Ophthalmology researchers and clinicians over the years have developed different 
systems for classifying the different stages of AMD,15,16 but to this date no classification 
system has been universally agreed upon. The Age-Related Eye Disease Study (AREDS) 
Research Group published a paper that described a classification system for AMD for 
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clinical application.  Early AMD was characterized by the presence of medium sized 
drusen with no changes in the pigment. Intermediate AMD was characterized by the 
presence of large drusen (over 125µm in size) and pigment changes. Late AMD was 
characterized by either choroidal neovascularization (wet AMD) or geographic atrophy 
(dry AMD).17 Figure 1 shows images of the different stages of AMD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Currently, there is no cure for AMD and research has been targeted at developing 
therapeutics and management strategies to prevent or slow down the progression of the 
disease. Antioxidant supplementation can be used to reduce the risk of advancing to 
choroidal neovascularization (CNV) in those with early AMD but is not effective at 
preventing the onset of the disease.19,20 Other treatment strategies include dietary and 
 
Figure 1: Different Stages of AMD: Panel (a) is the fundus of a normal eye. Panel 
(b): Patient with early AMD. A few small drusen can be seen. Panel (c): Patient with 
intermediate AMD with large drusen present. Panel (d): Patient with choroidal 
neovascularization with hemorrhaging. Panel (e): Patient with geographic atrophy 
where there has been hypopigmentation of the retinal pigmented epithelium. Panel (f): 
Scarring as a result of choroidal neovascularization.18   
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lifestyle modifications and anti-vascular endothelial growth factor (anti-VEGF) therapy, a 
very common treatment for CNV.21-24 
 
The Role of the Retinal Pigment Epithelium in AMD 
The RPE is a monolayer of cells in the outer portion of the retina that is located 
between the photoreceptor cell layer of the retina and the Bruch’s membrane of the 
choroid. The RPE performs several functions that are vital for a properly functioning 
retina. Some of the roles of the RPE include light absorption, nutrient and metabolic 
waste transport, phagocytosis of the photoreceptor outer segments, secretion of growth 
factors and cytokines such as platelet-derived growth factor (PDGF) and vascular 
endothelial growth factor (VEGF), visual product cycling, and maintenance of the blood-
retina barrier.25 
As a result of its normal functions, the RPE is exposed to significant oxidative 
stress on a continuous basis. One source of oxidative stress is the electron transport chain 
in the mitochondria which is responsible for oxidative phosphorylation to produce ATP 
for energy. Electrons from the electron transport chain can escape and react with oxygen 
to form reactive oxygen species (ROS). Uncontrolled accumulation of ROS may lead to 
oxidative damage and cell death.26 Phagocytosis of photoreceptor outer segments is 
another source of oxidative stress to the RPE as the outer segments have already been 
damaged by photo-oxidation from light absorption.25 In order to prevent oxidative stress, 
the RPE relies on a high level of antioxidant enzymes which are regulated in part by the 
transcription factor NFE2L2 (also known as NRF2).27 
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There is plenty of evidence in the literature that demonstrates that RPE 
dysfunction due to oxidative stress has been found to cause the progression of AMD.28,29 
Studies in animals have shown that altering oxidative phosphorylation or increasing 
oxidative stress in the retina or RPE shows some of the same features that are seen in 
AMD.30-34 It was also found that in aged eyes or eyes with AMD, there was increased 
mitochondrial DNA damage due to oxidative stress and a decrease in the expression of 
certain components of the antioxidant mechanism.35-37 It also has been found by prior 
studies that loss of mitochondria integrity, uncontrolled autophagy, and inflammosome 
activation are part of AMD development and these caused by oxidative stress which 
shows that RPE dysfunction plays a critical role in the role in the progression of AMD.38-
43       
 
PGC1 Isoforms 
 The peroxisome proliferator-activated receptor-gamma coactivator 1α and β 
(PGC1A and PGC1B) are found in many tissues and organs of the body such as the heart, 
kidneys, liver, skeletal muscle, and the brain and are critical regulators of mitochondrial 
metabolism. They interact with DNA binding transcription factors such as estrogen-
related receptor alpha (ESRRA), nuclear respiratory factor 1 and 2 (NRF1 and NRF2) in 
order to activate genes that regulate certain mitochondrial functions which are integral for 
metabolism.44,45 Some of the mitochondrial functions that the PGC1 isoforms have the 
ability to regulate include mitochondrial biogenesis, the electron transport chain, β-
oxidation of fatty acids, and the Krebs cycle.46-48  
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PGC1s also play a role in protecting the cell from oxidative damage. As 
mentioned before, one source responsible for oxidative stress is the electron transport 
chain in the mitochondria. One way PGC1s protect the cell from oxidative damage is by 
inducing uncoupling proteins which reduce the inner mitochondrial membrane potential 
to slow down production of ROS. Another way is by inducing antioxidant enzymes such 
as superoxide dismutases (SODs) and catalases (CATs) that modify the ROS to be less 
reactive and damaging to the cell.49  
The role of PGC1s have been previously studied in other tissues and organs. 
While PGC1A and PGC1B share certain transcriptional factor targets and functions, there 
are instances where the roles of PGC1A and PGC1B differ depending on the tissue or 
organ. It has been shown that PGC1A expression protected neurons from oxidative 
stress.49 In type I (slow-twitch) muscle cells, PGC1A has been shown to increase 
mitochondrial metabolism.50 In the liver, PGC1A is activated and induces 
gluconeogenesis in response to starvation.51 PGC1B is activated upon the intake of 
dietary fat and coactivates the SREBP transcription factor family to induce lipogenesis.48 
In the retina, PGC1A has been shown to regulate normal and pathological angiogenesis 
through the induction of VEGF-A expression 52 and protect the retina from damage due 
to pathologic light exposure.53 A previous study from our group has shown that during 
RPE maturation, PGC1A expression is increased while PGC1B expression is repressed in 
mature RPE. It was found that PGC1A expression in the RPE cell protects it from 
oxidative damage by inducing the expression of important antioxidant enzymes to reduce 
 6 
the oxidative stress caused by the normal physiological functions of the RPE cell.54 
However, not much is known about the role that PGC1B plays in the RPE cell. 
 
Preliminary Clinical and Experimental Data 
There is clinical and experimental evidence suggesting that PGC1B is involved in 
AMD progression. Preliminary data from our laboratory has shown that oxidized LDL, 
which is a component of drusen,55 triggers RPE death by activating the NRLP3 
inflammosome pathway 56 (Figure 2A) and it also induced PGC1B, but not PGC1A, 
expression (Figure 2B). Clinical data (Courtesy of Dr. Margaret DeAngelis, John A. 
Moran Eye Center, Salt Lake City, UT) shows that PGC1B expression is specifically 
increased in the RPE of patients with neovascular AMD compared to control subjects or 
intermediate (AREDS3) AMD patients (Table 1). Furthermore, there is experimental 
evidence that overexpression of PGC1B leads to the suppression of anti-angiogenic 
factors such as thrombospondin-1 (THBS1) and pigment epithelium-derived growth 
factor (PEDF) (Figure 3). 
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Table 1: Increased PGC1B Expression Seen In CNV Patients. RNA-sequencing 
analysis shows that PGC1B (PPARGC1B) expression is induced in patients with 
choroidal neovascularization (Courtesy of Dr. Margaret DeAngelis, John A. Moran 
Eye Center, Salt Lake City, UT). 
RPE/Choroid Macular Region (n=27 eyes from 27 individuals) 
  
Neovascular vs 
Normal 
AREDS3 vs 
Normal 
Neovascular vs 
AREDS3 
GENE 
Fold 
Change 
P 
value 
Fold 
Change 
P 
value 
Fold 
Change 
P 
value 
PPARGC1A 1.120 0.8579 1.503 0.2874 -1.342 0.4910 
PPARGC1B 1.910 0.0005 -1.015 0.9820 1.937 0.0004 
 
 
Figure 2: PGC1B expression is induced by oxidized LDL (oxLDL). (A) Measure 
of LDH release as a marker of cell death in human fetal RPE (hfRPE) after exposure 
to 500µg/ml of LDL or oxLDL for 48 hours (n=7). Data analyzed using ANOVA. 
Figure courtesy of Dr. Patricia D’Amore, Schepens Eye Research Institute, Boston, 
MA. (B) PGC-1α (PGC1A) and PGC-1β (PGC1B) expression levels measured by 
qPCR in hfRPE after treatment with 500µg/ml of LDL or oxLDL for 24 hours (n=4). 
Data analyzed using Student’s T test. Figure courtesy of Dr. Magali Saint-Geniez, 
Schepens Eye Research Institute, Boston, MA. 
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Figure 3: PGC1B overexpression suppresses anti-angiogenic growth factors. 
qPCR analysis shows that while PGC1A overexpression induces the expression of 
THBS1 and PEDF, PGC1B overexpression suppressed these anti-angiogenic genes in 
the RPE (n=3-4). Figure courtesy of Dr. Magali Saint-Geniez, Schepens Eye Research 
Institute, Boston, MA. 
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Specific Aims 
 The PGC1 isoforms are coactivators that are master regulators of mitochondrial 
metabolism. While they share a number of transcription factor targets and sometimes 
exert similar effects, prior research has shown that the PGC1 isoforms have divergent 
effects that is tissue or organ-specific. A previous study has found that RPE cell 
maturation is associated with PGC1A induction and PGC1B repression. Furthermore, 
preliminary data from our lab showed that PGC1B is upregulated by cytotoxic doses of 
oxidized LDL, found to be specifically induced in patients with CNV, and suppresses 
anti-angiogenic growth factors. Based on these observations, we believe that expression 
of PGC1B may play a deleterious role in the RPE cell. 
  
Aim 1: To show that PGC1B gain of function has a pro-oxidative effect leading to RPE 
damage and dysfunction. 
Aim 2: To show that PGC1B expression in RPE promotes choroidal neovascularization. 
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METHODS 
 
Cell Culture 
 The human retinal pigmented epithelial (ARPE-19, CRL-2302) cell line was 
obtained from the American Type Culture Collection (ATCC, Manassas, VA). ARPE-19 
cells were maintained and expanded in DMEM/F12 media (Lonza, Walkersville, MD) 
supplemented with 10% Fetal Bovine Serum (FBS, Atlanta Biologicals, Lawrenceville, 
GA) and 1% penicillin and streptomycin (Lonza). The cells were incubated at 37˚C and 
5% CO2 and split 1:3 when confluent. 
The rhesus monkey chorioretinal endothelial (RF/6A) cell line was generously 
donated by Dr. Budd A. Tucker (Wynn Institute for Vision Research, University of Iowa 
Carver College of Medicine, Iowa City, IA). The cells were cultured using MEM media 
(Sigma-Aldrich, Saint Louis, MO) supplemented with 10% FBS (Atlanta Biologicals), 
1% penicillin and streptomycin (Lonza), 1% L-glutamine (2mg/L, Lonza), and 1% 1mM 
sodium pyruvate (Gibco by Life Technologies, Grand Island, NY) and incubated at 37˚C 
and 5% CO2. Cells were split 1:3 or 1:4 when confluent. 
 
Evaluation of Adenovirus Transduction Efficiency 
 ARPE-19 cells were seeded at a density of 20,000 cells/cm2 and were incubated at 
37˚C and 5% CO2. Twenty-four hours later, the cells were infected with control 
adenovirus (Ad-GFP, conc: 1.3 x 105 pfu/ml), adenovirus containing a mouse PGC1A 
sequence (Ad-PGC1A, conc: 1.1 x 105 pfu/ml), or adenovirus containing a mouse 
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PGC1B sequence (Ad-PGC1B, conc: 1.5 x 105 pfu/ml) at a multiplicity of infection 
(MOI) of 30, 100, or 300 in serum free media. The Ad-PGC1A and Ad-PGC1B vectors 
both consist of the GFP gene and the mouse PGC1A and PGC1B genes are located 
downstream from separate cytomegalovirus (CMV) promoters.57 Forty-eight hours later, 
the cells were imaged using an EVOS fluorescent microscope (Life Technologies, 
Carlsbad, CA) and the percentage of transduced GFP-positive cells was evaluated.  
 
RNA Extraction and Quantitative PCR (qPCR) 
 Total RNA was isolated from cells using RNA-Bee (Tel-Test Inc., Friendswood, 
Texas, USA) according to the manufacturer’s directions. RNA pellets were reconstituted 
using Tris-EDTA buffer solution (Ambion, AM9849). RNA concentration and purity 
were measured using the NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, 
Wilmington, DE). One microgram of RNA was reverse-transcribed into complementary 
DNA (cDNA) using the iScript cDNA synthesis kit (Bio-Rad Laboratories, Hercules, 
CA) according to manufacturer’s directions. Quantitative polymerase chain reaction 
(qPCR) was performed using the Lightcycler480 system with the Fast Universal SYBR 
Green Master Mix (Roche Life Sciences, Indianapolis, IN) to analyze the expression of 
antioxidant and transcription factor genes that are regulated by the PGC1 isoforms. Table 
2 contains a list of the primers used and their sequences. Relative gene expression was 
calculated using the 2-ΔΔCt method and normalized using the housekeeping genes B2M, 
HPRT1, and PPIA.      
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Table 2: Primer Sequences for qPCR 
Gene 
Abbreviation 
Gene Name  Primer Sequence  
eGFP 
Enhanced Green Fluorescent 
Protein  
Forward (5'-3') AAGCAGCACGACTTCTTCAAGTC 
Reverse (5'-3') TCGCCCTCGAACTTCACCTC 
qhB2M Human Beta-2-microglobin 
Forward (5'-3') AAGATTCAGGTTTACTCACGTC 
Reverse (5'-3') TGATGCTGCTTACATGTCTCG 
qhCAT Human Catalase 
Forward (5'-3') ACTTTGAGGTCACACATGACATT 
Reverse (5'-3') CTGAACCCGATTCTCCAGCA 
qhESRRA 
Human Estrogen-related 
receptor alpha 
Forward (5'-3') TATGGTGTGGCATCCTGTG 
Reverse (5'-3') GTCTCCGCTTGGTGATCTC 
qhFOXO3 Human Forkhead box O3 
Forward (5'-3') CTTCAAGGATAAGGGCGACA 
Reverse (5'-3') AGTTCCCTCATTCTGGACCC 
qhHMOX1 
Human Heme oxygenase 
(decycling) 1 
Forward (5'-3') GCCAGCAACAAAGTGCAAG 
Reverse (5'-3') GAGTGTAAGGACCCATCGGA 
qhHPRT1 
Human Hypoxanthine Guanine 
Phosphoribosyltransferase 1 
Forward (5'-3') CCTGGCGTCGTGATTAGTGAT 
Reverse (5'-3') AGACGTTCAGTCCTGTCCATAA 
qhNFE2L2 
Human Nuclear factor, erythroid 
2-like 2 
Forward (5'-3') TCCAGTCAGAAACCAGTGGAT 
Reverse (5'-3') GAATGTCTGCGCCAAAAGCTG 
qhNRF1 
Human Nuclear respiratory 
factor 1 
Forward (5'-3') GCTGATGAAGACTCGCCTTCT 
Reverse (5'-3') TACATGAGGCCGTTTCCGTTT 
qhPGC1A 
Human Peroxisome proliferator-
activated receptor gamma, 
coactivator 1 alpha 
Forward (5'-3') GTCACCACCCAAATCCTTAT 
Reverse (5'-3') ATCTACTGCCTGGAGACCTT 
qhPGC1B 
Human Peroxisome proliferator-
activated receptor gamma, 
coactivator 1 beta 
Forward (5'-3') CCACATCCTACCCAACATCAAG 
Reverse (5'-3') CACAAGGCCGTTGACTTTTAGA 
qhPPARA 
Human Peroxisome proliferator-
activated receptor alpha 
Forward (5'-3') ATCGAATGTAGAATCTGCGGG 
Reverse (5'-3') TCGCACTTGTCATACACCAG 
qhPPIA 
Human Peptidylprolyl isomerase 
A (cyclophilin A) 
Forward (5'-3') CAGACAAGGTCCCAAAGACAG 
Reverse (5'-3') TTGCCATCCAACCACTCAGTC 
qhSOD2 
Human Superoxide dismutase 2, 
mitochondrial 
Forward (5'-3') CAGACCTGCCTTACGACTATGG 
Reverse (5'-3') CGTTCAGGTTGTTCACGTAGG 
qhTXN2 Human Thioredoxin 2 
Forward (5'-3') TGATGACCACACAGACCTCG 
Reverse (5'-3') ATCCTTGATGCCCACAAACT 
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Cytotoxicity Assay 
Cells were seeded in 48 well plates (Corning Inc., Corning, NY) using 
DMEM/F12 media with 10% FBS and 1% penicillin and streptomycin. The plates were 
then incubated at 37˚C, 5% CO2. After 24 hours, the media was changed for serum free 
DMEM/F12 media. The plates were incubated at 37˚C and 5% CO2 for another 24 hours, 
after which the media was replaced with fresh new serum free DMEM/F12 media and an 
appropriate concentration of H2O2 (0.5 - 1.0 µM) was added. For adenovirus-transduced 
cells, application of H2O2 was done 48 hours after adenovirus transduction. 18 hours after 
the application of H2O2, the supernatant from the wells were collected and transferred to 
a 96 well plate (Corning Inc., Corning, NY) for the cytotoxicity assay. Lactate 
dehydrogenase (LDH) release from the cytoplasm of damaged cells was measured using 
the CytoTox 96 Non-Radioactive Cytotoxicity Assay kit (Promega Corp, Madison, WI) 
according to the manufacturer’s directions. Results of the assay were quantified using the 
Table 2 Continued. Primer sequences for qPCR 
Gene 
Abbreviation 
Gene Name  Primer Sequence  
qmB2M Mouse Beta-2-microglobin  
Forward (5'-3') TTCTGGTGCTTGTCTCACTGA 
Reverse (5'-3') CAGTATGTTCGGCTTCCCATTC 
qmPGC-1α 
Mouse Peroxisome proliferator-
activated receptor gamma, 
coactivator 1 alpha 
Forward (5'-3') AGCCGTGACCACTGACAACGAG 
Reverse (5'-3') GCTGCATGGTTCTGAGTGCTAAG 
qmPGC-1β 
Mouse Peroxisome proliferator-
activated receptor gamma, 
coactivator 1 beta 
Forward (5'-3') CCCAGCGTCTGACGTGGACGAGC 
Reverse (5'-3') CCTTCAGAGCGTCAGAGCTTGCTG 
qmPPIA 
Mouse Peptidylprolyl isomerase 
A (cyclophilin A) 
Forward (5'-3') GAGCTGTTTGCAGACAAAGTTC 
Reverse (5'-3') CCCTGGCACATGAATCCTGG 
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ELISA plate reader (Dynatech Medica, Guernsey, UK) to measure the absorbance at 
490nm. 
 
Choroidal Sprouting Assay 
 The choroidal sprouting assay was conducted according to a previously published 
method 58 with some modifications. Eyes were collected from 3 week-old C57Bl/6J mice 
(The Jackson Laboratory, Bar Harbor, ME) and immediately placed in cold phosphate 
buffered saline (PBS, Sigma-Aldrich) containing 1% penicillin and streptomycin. Under 
sterile conditions, the anterior portion of each eye was dissected out and the retina was 
removed leaving the choroid/sclera complex intact. The posterior eyecups were cut 
radially, transferred into 5cm dishes, and maintained inside a large drop (50µl) of serum 
free DMEM media (Lonza) supplemented with 1% penicillin and streptomycin (Lonza). 
After all the tissues were collected, the media was replaced with either 50µl of Ad-GFP 
(conc: 1 x 105 pfu/µl) or 50µl of Ad-PGC1B (conc: 1 x 105 pfu/µl) diluted in DMEM. 
The samples were incubated for 6 hours at 37˚C and 10% CO2 for efficient adenoviral 
infection. After the incubation period, the media was removed and the samples were 
quickly washed 2-3 times using EGM-2 media with 5% FBS and 1% penicillin and 
streptomycin. Using a 1mm punch biopsy (Integra Miltex, York, PA), 4-5 samples were 
punched out from the peripheral region of the choroid/sclera complex. Each explant was 
added to a sterile 12mm coverslip coated with 30µl of growth factor-reduced matrigel 
(Corning, Corning, NY). The explants were incubated at 37˚C and 5% CO2 for 10 
minutes to allow the matrigel to solidify. Afterwards, the coverslips containing the 
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embedded explants were placed into a 24 well plate with 0.5ml of EGM-2 5% FBS, 1% 
penicillin and streptomycin added. Every 48 hours, the media was replaced with fresh 
new EGM-2 media with 5% FBS, 1% penicillin and streptomycin and the explants were 
imaged using an inverted microscope. The sprouting area for each explant was quantified 
using the ImageJ software (National Institutes of Health, version 1.51h).  
 
Immunohistochemistry  
 Forty-eight hours following adenoviral infection, the choroidal explants were 
fixed using 4% paraformaldehyde (PFA, Electron Microscopy Sciences, Hatfield, PA) 
and incubated at room temperature for 20 minutes. The fixative was removed and the 
samples were washed 3 times for 20 min with PBS before incubation for 1 hour in a 
blocking buffer that consisted of 1% bovine serum albumin (BSA) and 0.1% Tween 
(Sigma-Aldrich) in PBS. The filamentous actin (F-actin) of the RPE was stained using a 
1:300 dilution of Alexa Flour 594 phalloidin (Invitrogen, Carlsbad, CA) followed by a 
wash with PBS. The cell nuclei were stained using a 1:1000 dilution of 4’, 6-diamidino-
2-phenylindole (DAPI) followed by another wash with PBS. Images were taken at 10X 
and 40X magnification using the Axioskop (Carl Zeiss Microscopy, Thornwood, NY). 
 
Conditioned Media Preparation  
 ARPE-19 cells were seeded using DMEM/F12 with 10% FBS and 1% penicillin 
and streptomycin in a 6 well plate at a density of 30,000 cells/cm2. The following day, 
one of the wells was trypsinized for cell counting using the counter coulter (Beckman 
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Coulter, Fullerton, CA). The media is then removed and replaced with serum free 
DMEM/F12 along with either Ad-GFP, Ad-PGC1A, or Ad-PGC1B at a MOI of 100. 
Eighteen hours after the adenovirus infection, the media was replaced with DMEM/F12 
media supplemented with 1% FBS and 1% penicillin and streptomycin and the cells were 
left to recover for 24 hours. After this period, the media was replaced with 2ml of 
DMEM/F12 with 1% FBS for 48 hours conditioning. After the conditioning period, the 
media was collected from each well, centrifuged at 1500 rpm for 5 minutes to remove 
large cellular debris and stored at -80˚C for later use. 
 
Cell Proliferation Assay 
 RF/6A cells were seeded in three 96 well plates at a density of 50,000 cells/well 
using MEM media with 10% FBS and 1% penicillin and streptomycin. The following 
day, the cells were starved overnight using DMEM/F12 media with 1% FBS. Afterwards, 
the media was removed and the cells were treated with conditioned media from either 
Ad-GFP, Ad-PGC1A, Ad-PGC1B, or untreated ARPE-19 cells. The MTT Vybrant kit 
was used according to the manufacturer’s instructions in order to perform the cell 
proliferation assay. The absorbance was measured at 540nm using the ELISA plate 
reader (Dynatech Medica, Guernsey, UK). 
 
Cell Migration Assay 
 Cell migration was evaluated using the standard cell scratch assay.59 RF/6A cells 
were seeded at confluency into 12 well plates. The following day, the growth media was 
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removed and cells were starved in DMEM/F12 media with 1% FBS and 1% penicillin 
and streptomycin overnight. Then the media was removed and a 200µl pipette tip was 
used to make a vertical scratch in the center of each well. Each well was washed twice 
with PBS to remove all floating cells and appropriate experimental conditioned media 
(CM) was added. The plates were incubated at 37˚C and 5% CO2 and images of the wells 
were taken at 0, 6, and 24 hours after the CM was applied to the wells using the EVOS 
microscope at 4X magnification. The area of the scratch was quantified using ImageJ 
software (National Institutes of Health, version 1.51h).  
 
Tube Formation Assay 
 Fifty microliters of basal membrane extract (BME) was added to each well of a 96 
well plate. Then, the plate was incubated at 37˚C for 1 hour to allow the BME to solidify. 
Meanwhile, confluent RF/6A cells that were serum starved overnight using MEM media 
were trypsinized, counted, and re-suspended in DMEM/F12 media with 1% FBS and 1% 
penicillin and streptomycin at a concentration of 1,000,000 cells/ml. Fifty microliters of 
the cell suspension (50,000 cells) were added to each well and the plate was then 
incubated at 37˚C and 5% CO2 for at least 1 hour to allow the cells to adhere to the BME. 
Once the cells adhered to the BME, the media was removed and replaced with 50 µl of 
CM. The plate was incubated at 37˚C and 5% CO2 for 10 hours. Images of tube formation 
were taken at 4X and 10X magnification using the EVOS microscope. 
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Statistical Analysis 
 Statistical analysis of data was performed using GraphPad Prism 5 software 
(GraphPad Software Inc., La Jolla, CA). Values are presented as mean ± SEM unless 
otherwise stated. The student’s t-test was used for analysis of experiments comparing two 
conditions whereas the one-way ANOVA with the Dunnett’s multiple comparison post 
test was used for analysis of experiments using three or more conditions. Statistical 
significance is denoted by the following: * P < 0.05, ** P < 0.01, *** P < 0.001, **** P 
< 0.0001. 
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RESULTS 
 
Gene Analysis of Adenovirus-Transduced ARPE-19 Cells  
 Total RNA was collected from ARPE-19 cells that were transduced at a MOI of 
300 with either Ad-GFP or Ad-PGC1B. qPCR was performed to determine how the gene 
expression of transcription factors regulating certain antioxidant and metabolic proteins 
were affected by overexpression of PGC1B in ARPE-19 cells compared to control cells 
(cells overexpressing ad-GFP). Quantification of qPCR data (Figure 4) demonstrated that 
PGC1B overexpression significantly induced the expression of the PPARA (p=0.0021), 
ESRRA (p=0.0005), SOD2 (p=0.0003), and TXN2 (p=0.0076) genes compared to the 
control cells. The analysis also showed that PGC1B repressed the expression of the 
PPARGC1A (p=0.0033), NFE2L2 (p=0.0023), and FOXO3 (p=0.0058) genes. There was 
no statistically significant difference between ARPE-19 cells overexpressing the 
PPARAGC1B gene and control ARPE-19 cells overexpressing the GFP gene in the 
expression of PPARAGC1B, CAT, HMOX1, and NRF1 genes. This shows that contrary to 
PGC1A,54 PGC1B represses the expression of essential antioxidant transcription factors 
and enzymes in the RPE which could result in increased oxidative stress within the cells.  
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Overexpression of PGC1B Leads to Increased Cytotoxicity in RPE Cells 
 The capability of PGC1B to induce RPE cell death under basal and pro-oxidative 
conditions was evaluated by measuring lactate dehydrogenase release (a marker of 
necrosis and late apoptosis) from ARPE-19 cells treated with or without hydrogen 
peroxide (H2O2). Hydrogen peroxide is a reactive oxygen species that is produced during 
mitochondrial respiration and phagocytosis of photoreceptor outer segments.60 Parental 
ARPE-19 cells were treated with 0, 250, 500, or 1000µM of H2O2 for 14 or 18 hours. 
Cell death increased in these cells in a time and dose dependent manner (Figure 5A). 
Then, ARPE-19 cells infected at MOI 100 with either Ad-GFP or Ad-PGC1B were 
 
Figure 4: PGC1B overexpression modulates key transcription factor genes. 
PGC1B overexpression in ARPE-19 cells leads to the repression of PPARGC1A 
(PGC1A) and transcription factors important for antioxidant enzyme expression 
such as FOXO3 and NFE2L2 while inducing the expression of transcription 
factors important for oxidative metabolism such as PPARA and ESRRA (n=3). 
Data analyzed using Student’s T test. 
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treated with 0 or 500µM H2O2 for 18 hours. It was demonstrated that ARPE-19 cells 
overexpressing PGC1B had a significantly higher percentage of cell death with and 
without H2O2 treatment than the control ARPE-19 cells treated with Ad-GFP (Figure 
5B). This shows that induction of PGC1B expression in the RPE places it at increased 
risk of dysfunction and cell death. 
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Figure 5: Overexpression of PGC1B Leads to Increased Cell Death. (A) 
The cytotoxic effect of H2O2 was tested on parental ARPE-19 cells in a time 
and dose dependent manner (n=5). Data analyzed using Two-way ANOVA. (B) 
ARPE-19 cells infected with Ad-PGC1B showed increased cell death compared 
to control ARPE-19 cells infected with Ad-GFP with and without H2O2 
treatment (n=5). Data analyzed using Two-way ANOVA. 
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Choroidal Sprouting Assay Shows Evidence that Overexpression of PGC1B Leads 
to Angiogenesis 
The pro-angiogenic effect of PGC1B was evaluated by performing a choroidal 
sprouting assay. This new ex vivo angiogenesis model allowed us to evaluate 
microvascular growth in an organotypic system.57 In order to characterize the effect of 
PGC1B expression in RPE on choroidal microvascular outgrowth, we first needed to 
develop a method for overexpressing PGC1B in choroidal explants as native healthy RPE 
cells do not express this gene.54 Using our previously characterized adenoviral method 
for infection of cell culture, we investigated the ability of Ad-GFP and Ad-PGC1B to 
efficiently infect RPE cells in live ocular posterior cups. Eyes were collected from young 
adult wild type albino mice (3 week old Swiss Webster). The inside of the posterior eye 
cups (RPE) were exposed to 25 x 105 pfu of Ad-GFP or Ad-PGC1B for 6 hours and 
maintained in culture for up to 48 hours to allow for the expression of the transduced 
genes. We used a combination of direct GFP detection and immunohistochemistry for the 
cytoskeleton marker F-actin to confirm high infection of both Ad-GFP and Ad-PGC1B of 
RPE cells in the posterior cups (Figure 6A). Total RNA was collected from the entire 
eyecup 48 hours following adenoviral infection and qPCR was performed to evaluate the 
gene expression levels of eGFP, Ppargc1a (PGC1A), and Ppargc1b (PGC1B). Analysis 
showed a robust increase in the gene expression of PGC1B in Ad-PGC1B treated 
eyecups when compared to the control Ad-GFP infected tissue (p<0.05). Importantly, we 
also confirmed that PGC1B overexpression does not alter basal expression of PGC1A 
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(Figure 6B). These results demonstrated that PGC1B was successfully overexpressed in 
the RPE cells of murine posterior eyecups that were adenovirus-transduced. 
 Once PGC1B gain of function in live ocular tissue was established, we performed 
a choroidal explant sprouting assay using 3 week old C57Bl/6J mice (Figure 7A). 
Quantification of the sprouting areas showed that after 6 days in culture, the explants 
with RPE overexpressing PGC1B had a larger sprouting area than explants with RPE 
overexpressing GFP (p=0.0127). After 8 days, the sprouting area for both conditions 
continued to increase. While the sprouting area of explants with RPE overexpressing 
PGC1B was still larger than the sprouting area of explants with RPE overexpressing 
GFP, the difference was not statistically significant (p=0.5187) (Figure 7B). The choroid 
sprouting assay demonstrated that overexpression of PGC1B in RPE increases choroidal 
angiogenesis. 
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Figure 6: Efficiency of PGC1B overexpression in mouse choroidal explants. 
(A) Immunostaining of Swiss Webster mice explants confirms that the RPE 
identified by their characteristic cuboidal shape (see F-actin staining) have been 
efficiently infected with either Ad-GFP or Ad-PGC1B. (B) Gene expression 
analysis of choroidal explants 48 hours after infection with either Ad-GFP or 
Ad-PGC1B (n=3). Data analyzed using Student’s T test. 
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Figure 7: Ex Vivo Choroid Sprouting Assay. (A) Photographs of choroidal 
explants and their sprouting area. Scale bar = 100µm. (B) Quantification of 
sprouting area shows that explants infected with Ad-PGC1B had an increased 
sprouting area compared to the control explants infected with Ad-GFP (n=9). Data 
analyzed using Student’s T test. 
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MTT Assay Shows That PGC1B Overexpression Increases RF/6A Cell Proliferation 
 Angiogenesis occurs via a series of complex cellular processes mainly associated 
with the proliferation and migration of endothelial cells. To better understand which of 
these phenomena was activated during PGC1B-induced choroidal sprouting, we first 
evaluated the effect of PGC1B overexpression on the ability of RPE to promote 
endothelial cell (EC) proliferation using the rhesus monkey chorioretinal cell line 
(RF/6A) as an EC model.  RF/6A cells were exposed to CM from untreated or infected 
ARPE-19 with Ad-GFP or Ad-PGC1B and their proliferation was evaluated using the 
MTT assay.  It was observed that proliferation of RF/6A cells was increased 24 (p<0.001) 
and 48 hours (p<0.0001) after treatment with CM from ARPE-19 cells infected with 
PGC1B as compared to control ARPE-19 cells infected with Ad-GFP (Figure 8). This 
shows further evidence that overexpression of PGC1B in RPE cells can lead to the 
secretion of factors that can promote angiogenesis in the choroid of the eye. 
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Cell Migration and Tube Formation Assays Show No Evidence of Angiogenesis as a 
Result of PGC1B Induction 
 In order to further investigate the pro-angiogenic effect of PGC1B, we performed 
a cell migration assay by making a vertical scratch through a monolayer of RF/6A cells 
and evaluating the area of scratch closure after 6 or 24 hours.  In one experiment, RF/6A 
cells were treated with basal unconditioned media (DMEM/F12 1% FBS), full 
unconditioned media (EGM-2 5% FBS), or conditioned media from uninfected ARPE-19 
cells. After 24 hours, cell migration was highest in RF/6A cells treated with full 
unconditioned media as the scratch closure was approximately 80%. There was a 
significant increase in cell migration for RF/6A cells that were treated with unconditioned 
 
Figure 8: Effect of ARPE-19 conditioned media on RF/6A proliferation. 
The increased optical density (OD) suggests that RF/6A proliferation was 
significantly increased over the control after 24 and 48 hours of treatment with 
conditioned media from ARPE-19 cells infected with Ad-PGC1B (n=3). Data 
analyzed using Two-way ANOVA followed by Sidak’s multiple comparison 
test. 
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full media (EGM-2 5% FBS) compared to RF/6A cells that were treated with 
unconditioned basal media (DMEM/F12 1% FBS) (p<0.0001). There was also a 
significant increase in cell migration for RF/6A cells treated with full unconditioned 
media compared to RF/6A cells treated with conditioned media from uninfected ARPE-
19 cells (p<0.0001). There was no significant difference in cell migration between RF/6A 
cells treated with unconditioned basal media and RF/6A cells treated with basal 
conditioned media from uninfected ARPE-19 cells (Figure 9A). 
 In another experiment, conditioned media from ARPE-19 cells was mixed at a 1:1 
ratio with the full unconditioned media. After 6 hours of incubation at 37°C, there was no 
significant difference in cell migration between RF/6A cells treated with conditioned 
media from uninfected ARPE-19 cells, RF/6A cells treated with conditioned media from 
Ad-GFP infected ARPE-19 cells, or RF/6A cells treated with conditioned media from 
Ad-PGC1B infected ARPE-19 cells. After 24 hours, the percent scratch closure for all 
three conditions was approximately 80% which was similar to the scratch closure for 
RF/6A cells treated with full unconditioned media after 24 hours. There was no 
significant difference in cell migration among the three conditions (Figure 9B).   
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 Conditions allowing for RF6A tube formation on BME were first tested. Two 
different media (MEM with 10% FBS and EGM-2 5% FBS) and two different cell 
A 
 
B 
 
Figure 9: Evaluating migratory activity of RF/6A cells. (A) RF/6A 
migration activity evaluated by percent scratch closure after treatment for 
24 hours with full unconditioned media (EGM2), basal unconditioned 
media (DMEM/F12), and basal conditioned media (ARPE-19 CM) (n=3). 
Data analyzed by One-way ANOVA followed by Tukey’s multiple 
comparisons test. (B) RF/6A migration evaluated by scratch closure after 
treatment with conditioned media mixed 1:1 with full unconditioned media. 
Data analyzed by Two-way ANOVA followed by Tukey’s multiple 
comparisons test. 
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densities (20,000 and 50,000 cells) were evaluated. Formation of tube-like structures 
following 6 hours of incubation at 37°C was only observed when 50,000 cells were 
plated and exposed to EGM-2 media (Figure 10). As with the scratch assay, we elected to 
test ARPE-19 derived CM mixed at a 1:1 ratio with EGM-2 5% FBS in order to evaluate 
the pro-angiogenic effect of PGC1B expression. Evaluation of CM from uninfected cells 
show significantly increased tube formation as shown by larger covered area (p=0.0045), 
tube length (p=0.0068), and branching points (p=0.0097) compared to non-conditioned 
media (Table 3). However, similar comparative analysis of CM from Ad-GFP and Ad-
PGC1B infected cells showed no significant change in the extent or characteristics of the 
tubes formed (Table 3), suggesting that contrary to our previous results using choroidal 
explants, PGC1B gain of function in ARPE-19 does not promote angiogenesis, at least 
under the conditions tested here.  
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Figure 10: Tube Formation Assay. Qualitative analysis shows that tube-like 
structures formed when cells were plated at 50,000 cells using EGM-2 media with 5% 
FBS. Scale bar = 500µm. 
Table 3: Tube Characteristics. Quantification of tube formation parameters for 
ARPE-19 CM shows significantly increased tube formation for uninfected cells as 
compared to non-conditioned media (BM). However, comparison between Ad-GFP 
and Ad-PGC1B infected ARPE-19 cells show no significant change (n=4). Data 
analyzed using Student’s T test. 
 
BM Uninfected P value Ad-GFP Ad-PGC1B P value
Covered 
Area (%)
15.45 ± 2.33 30.03 ± 6.18 **0.0045 25.62 ± 4.28 23.43 ± 4.12 0.4865
Tube Length 
(px)
12187 ± 1240 20270 ± 3814 **0.0068 17102 ± 2357 14819 ± 2280 0.2132
Branching 
Points
8.5 ± 3 56.25 ± 25.46 **0.0097 38.25 ± 15.65 24.75 ± 11.79 0.2173
Number of 
Loops
0 ± 0 11.75 ± 11.59 0.0888 3.75 ± 2.87 1.25 ± 1.5 0.1737
Tube Characteristics
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DISCUSSION 
 
 In this study, we show that induction of PGC1B increases RPE metabolic activity 
by inducing the expression of the PPARA and ESRRA genes. These genes encode for 
transcription factors that regulate metabolic activities in the RPE cell such as lipid and 
amino acid metabolism.61 As the metabolism of the RPE cell is increased, the activity of 
the electron transport chain is increased at the same time, leading to superoxide 
accumulation. Previous work in our lab has shown that PGC1A gain of function is 
accompanied by both an increase in PPARA and ESRRA expression (that will induce 
oxidative metabolism) and in two critical antioxidant transcriptional regulators, FOXO3 
and NFE2L2.54 Here we show that, contrary to PGC1A, PGC1B gain of function greatly 
represses FOXO3 and NFE2L2 expression which could alter the level of antioxidant 
enzymes in RPE and induce ROS accumulation. Indeed we showed that while SOD2 
gene expression is significantly increased when PGC1B is overexpressed, the CAT gene 
is not (Figure 2). SOD2 is responsible for converting the ROS produced as byproducts of 
the electron transport chain into hydrogen peroxide and diatomic oxygen.62 Catalase is 
needed to convert hydrogen peroxide into water and diatomic oxygen.63 Without 
increased CAT expression, accumulation of hydrogen peroxide within the RPE cell 
would increase basal and H2O2-dependent cell death, which was confirmed in this study 
(Figure 3).  
 In addition to promoting oxidative damage and cell death in RPE, clinical 
evidence suggests that increase in PGC1B may promote choroidal neovascularization. 
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We were able to confirm this hypothesis by adenovirally expressing PGC1B (normally 
repressed) in the RPE of entire mouse posterior eye cups that were subsequently used in a 
choroidal sprouting assay. However, subsequent analysis of the different cellular 
processes involved in microvascular sprouting, i.e. proliferation and migration of 
choroidal endothelial cells exposed to conditioned media of native or transduced ARPE-
19, led to contradictory results. RF/6A migration and tube formation was poor or 
nonexistent when 100% conditioned media from infected ARPE-19 cells was used. It was 
only when the conditioned media was mixed at a 1:1 ratio with a highly enriched media 
used for endothelial cell expansion that robust cell migration and tube formation was 
observed. But this demonstrates that cell migration and tube formation occurred only 
because a more pro-angiogenic medium was being used and not because of the 
conditioned media alone. Since it was shown in the preliminary data that PGC1B 
suppresses the activity of anti-angiogenic factors, it must be questioned whether the 
RF/6A is the correct endothelial cell model to evaluate PGC1B’s angiogenic potential. 
According to the ATCC, the RF/6A cell line was spontaneously transformed and 
passaged over 450 times 64 which means that it may have lost some of its original cellular 
characteristics. Alternatives that can be used include iPSC-derived choroid endothelial 
cells 65 and human retinal endothelial cells. Another alternative are primary human 
choroidal endothelial cells, but concerns have been raised about access to fresh donor 
samples, high variability in the samples obtained, and loss of cell characteristics after 
isolation and expansion in vitro.66,67 
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Also, the results of the MTT assay have to be called into question. The MTT 
assay uses metabolic activity, specifically the activity of succinate dehydrogenase in the 
mitochondria, as a measure of the number of living cells present.68 Increased activity of 
the enzyme theoretically should mean that there are more cells present. Since 
overexpression of PGC1B has been shown in this study to increase metabolic activity 
(Figure 2), it is possible that there was an increase in metabolic activity of the RF/6A 
cells but not a corresponding increase in cell number. However, it is important to note 
that PGC1A overexpression, which also leads to increased mitochondrial biogenesis and 
function, was not associated with increased MTT reduction. Nevertheless, these results 
must be confirmed using other measures of cell proliferative activity such as 
bromodeoxyuridine (BrdU) incorporation, flow cytometry analysis of DNA content 
and/or ki-67 expression.  
 It is interesting to note that this study has shown that PGC1B overexpression in 
ARPE-19 cells did not significantly affect endogenous PGC1B gene expression levels but 
led to the suppression of PGC1A. Iacovelli et al have shown that maturation of RPE cells 
in vitro leads to the induction of PGC1A expression while PGC1B expression is 
repressed.54 The same study has shown that induction of PGC1A promotes the expression 
of transcription factors such as FOXO3 and NFE2L2 that regulate antioxidant enzymes 
that protect the RPE cell from cell dysfunction and death due to oxidative stress. An 
important question that would need to be answered through further investigation is 
whether the suppression of FOXO3 and NFE2L2 is caused directly by PGC1B expression 
or by the suppression of PGC1A.  
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 Since this study has confirmed that PGC1B has detrimental effects on the RPE 
cell, this provides opportunities for further research to be conducted to develop novel 
therapeutic strategies in order to block the unfavorable effects of PGC1B to ameliorate 
some of the symptoms of AMD. While no loss of function studies were performed in this 
study, it is imperative to evaluate how loss of function of PGC1B would affect the RPE 
cell and determine whether silencing PGC1B expression would be beneficial in 
combating the harmful effects of AMD. Another strategy is to potentially target signaling 
factors upstream of PGC1B to prevent its upregulation, although further investigation 
would be needed to fully comprehend the mechanism of PGC1B induction.  
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